Health Affairs October 24, 2024
Richard Hughes IV, William Walters, Sara Devaraj

The Food and Drug Administration’s (FDA) recent authorization of FluMist for at-home administration marks the beginning of a new chapter in vaccine access and delivery. Before now, self-administered vaccines have been as elusive as they are full of promise. The FDA’s decision will be the first to allow self-administration, beginning with the 2025–26 respiratory season and will require a prescription.

Traditionally, patients received vaccinations at a physician’s office, but vaccination is becoming increasingly de-medicalized. While most young children still receive regular vaccinations in their pediatrician’s office, adolescent and adult patients are now able to access vaccines across many different settings of care. The ever-increasing role of pharmacies as vaccination sites is reflective of the shift. The home represents yet a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
After slow start, ACA enrollment takes off
FDA updates definition of 'healthy'
CMS says record 16.6 million have signed up for Jan. 1 Marketplace coverage
How America Lost Control of the Bird Flu, Setting the Stage for Another Pandemic
How Mount Sinai doubled its hospital-at-home program

Share This Article